stocks · Friday, May 1, 2026 · 2 min
Buy META at $612.99, Stop $595.00: Q1 Earnings Beat Overshadowed by Capex Hike
Meta dropped 9.2% after raising 2026 capex guidance to $125B to $145B, despite beating Q1 revenue and EPS estimates. The sell-off prices in fear about future spending while ignoring 33% revenue growth and 41% operating margins.
Your guide reads 50+ feeds so you do not have to. Every post is drafted by Nivéstor’s research engine, which queries Claude (Anthropic) across prediction markets, government filings, on-chain data, hedge-fund moves, and more, then renders the result against a fixed editorial template. No human edits the draft before publication. Methodology · Track record.
Aim for $653.00: April 23 support zone ($653.05 intraday low) that should act as first resistance on recovery
Aim for $700.00: JPMorgan new price target ($725) discounted 3.5% for conservative margin; also a psychological round number
Why this size: Risk 0.5% of account at stop. Stop distance is 2.94% below entry ($612.99 to $595.00). Computed position = 0.5% / 2.94% = 17.0%. Capped at 8% for single-stock concentration limit.
When you'd hold this: 2 to 6 weeks, around Q2 revenue tracking, AI monetization updates through June 2026
Meta reported Q1 revenue of $56.31 billion (beating estimates of $55.45 billion) and EPS of $7.31 (beating $6.78)12. The stock is down 9.2% because management raised full-year capex guidance to $125 billion to $145 billion, up from $115 billion to $135 billion3. The market is punishing forward spending plans while the current business accelerates at the fastest rate in years.
Why this dip is buyable
The quarter itself was strong. Revenue grew 33% year-over-year, operating margins hit 41%, and free cash flow came in at $12.39 billion. The company is sitting on $81.18 billion in cash1. This is not a business in distress. The sell-off is entirely about the pace of future investment, not current performance.
Analyst consensus still points significantly higher. Of 45 covering analysts, 44 maintain Buy or Overweight ratings. The consensus price target is $854.46, implying 39% upside from today's price. Even JPMorgan, which downgraded to Neutral, set a $725 target, 18% above the current level45.
The broader market is at all-time highs with fear sentiment. SPY printed a 52-week high at $721.40 today while the Crypto Fear and Greed Index reads 26 (Fear)6. This divergence, strong prices with fearful positioning, historically resolves higher. A beaten-down mega-cap in a rising market tends to mean-revert.
Technical support held at $600. Yesterday's intraday low was exactly $600.00, aligning with the 61.8% Fibonacci retracement of April's rally from $559.70 to $691.52. Today the stock is trading above that level, suggesting buyers stepped in at that zone.
Capex scares in prior cycles have been buyable. Meta went through an identical capex panic in 2022 to 2023 around Reality Labs spending. The stock sold off, the business kept growing, and the market eventually re-rated higher once ad revenue growth proved the investment thesis. The playbook here is the same: strong ad revenue growth funds aggressive AI investment.
What would change the thesis
A daily close below $595.00. This would break the $600 psychological level and the Fibonacci support. Below that, the next floor is $573 (early April low), and momentum would shift decidedly bearish.
Q2 revenue guidance miss on the call. Management guided Q2 revenue of $58 billion to $61 billion, bracketing the $59.50 billion consensus. If subsequent commentary or channel checks suggest the lower end is more likely, the capex/revenue ratio story worsens.
Regulatory escalation on AI spending. If antitrust scrutiny specifically targets AI infrastructure buildouts at Meta's scale, the capex could become a liability rather than a growth enabler.
Another capex raise. If management signals at any investor event that $145 billion is not the ceiling, the market will sell again.
Not financial advice. Do your own research.